Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12226418 | Dosing regimen for the treatment of PI3K related disorders | Albert Assad, Xuejun Chen | 2025-02-18 |
| 12226419 | Topical formulation for a JAK inhibitor | Bhavnish Parikh, Bhavesh Shah | 2025-02-18 |
| 12150943 | JAK1 pathway inhibitors for the treatment of gastrointestinal disease | Paul Smith, Gregory F. Hollis | 2024-11-26 |
| 12151026 | Sustained release dosage forms for a JAK1 inhibitor | Bhavnish Parikh, Dilip P. Modi, Trupti Sheth | 2024-11-26 |
| 11896717 | Sustained-release dosage forms of ruxolitinib | Yong Ni, Bhavnish Parikh, Susan Erickson-Viitanen, William V. Williams | 2024-02-13 |
| 11628162 | Methods of treating cancer with an FGFR inhibitor | Tao Ji | 2023-04-18 |
| 11596632 | JAK1 pathway inhibitors for the treatment of gastrointestinal disease | Paul Smith, Gregory F. Hollis | 2023-03-07 |
| 11590136 | Topical formulation for a JAK inhibitor | Bhavnish Parikh, Bhavesh Shah | 2023-02-28 |
| 11576864 | Sustained-release dosage forms of ruxolitinib | Yong Ni, Bhavnish Parikh, Susan Erickson-Viitanen, William V. Williams | 2023-02-14 |
| 11576865 | Sustained-release dosage forms of ruxolitinib | Yong Ni, Bhavnish Parikh, Susan Erickson-Viitanen, William V. Williams | 2023-02-14 |
| 11571425 | Topical formulation for a JAK inhibitor | Bhavnish Parikh, Bhavesh Shah | 2023-02-07 |
| 11337927 | Sustained-release dosage forms of ruxolitinib | Yong Ni, Bhavnish Parikh, Susan Erickson-Viitanen, William V. Williams | 2022-05-24 |
| 11219624 | Topical formulation for a JAK inhibitor | Bhavnish Parikh, Bhavesh Shah | 2022-01-11 |
| 11045421 | Sustained release dosage forms for a JAK1 inhibitor | Bhavnish Parikh, Dilip P. Modi, Trupti Sheth | 2021-06-29 |
| 10874616 | Sustained-release dosage forms of ruxolitinib | Yong Ni, Bhavnish Parikh, Susan Erickson-Viitanen, William V. Williams | 2020-12-29 |
| 10869870 | Topical formulation for a JAK inhibitor | Bhavnish Parikh, Bhavesh Shah | 2020-12-22 |
| 10758543 | Topical formulation for a JAK inhibitor | Bhavnish Parikh, Bhavesh Shah | 2020-09-01 |
| 10561616 | Sustained release dosage forms for a JAK1 inhibitor | Bhavnish Parikh, Dilip P. Modi, Trupti Sheth | 2020-02-18 |
| 10166191 | Sustained-release dosage forms of ruxolitinib | Yong Ni, Bhavnish Parikh, Susan Erickson-Viitanen, William V. Williams | 2019-01-01 |
| 9655854 | Sustained release dosage forms for a JAK1 inhibitor | Bhavnish Parikh, Dilip P. Modi, Trupti Sheth | 2017-05-23 |